AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2015

Aug 28, 2015

34301_dirs_2015-08-28_9d81a00f-d0dc-44bc-aae5-bd81e68c628e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-08-26

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-26	Common Stock	P	25000	$0.327	Acquired	582385	Indirect
2015-08-27	Common Stock	P	50000	$0.2992	Acquired	632385	Indirect

Footnotes

F1: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust.

F2: The shares were purchased in multiple open market transactions ranging in price from $0.297 to $0.30 per share, with a weighted average price of $0.2992 (as reported above).